Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmj-2022-074325
PubMed Identifier: 37487623
Publication URI: http://europepmc.org/abstract/MED/37487623
Type: Journal Article/Review
Volume: 382
Parent Publication: BMJ (Clinical research ed.)
ISSN: 0959-8138